ThomasDGazdaMDDLFAPA, FASAM
Psychiatry • Phoenix, AZAddiction, Psychopharmacology, Psychosomatic Medicine, Integrative Psychiatry
Psychiatrist and Psychoanalyst
Dr. Gazda is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3033 N Central Ave
Ste 700
Phoenix, AZ 85012Phone+1 602-230-7373Fax+1 602-257-8029
Summary
- Dr. Thomas Gazda is a psychiatrist and psychoanalyst in Scottsdale, AZ and is affiliated with St. Luke's Medical Center, Salt River People Indian Community, IMA Research, Soberman's Estate and private practice. He received his medical degree from University of Illinois College of Medicine and has been in practice 38 years. He specializes in psychiatry, psychoanalysis, clinical research, addiction, and psychopharmacology. Board Cert. APFP '82 - '89 UVM, Psychiatry '86 UVM, ongoing, APPM Addiction 2018 - 2028, Member, International Psychoanalytical Association '90 - 2000 through C.P.S. Montreal, DLFAPA, FASAM.
Education & Training
University of Vermont Medical CenterResidency, Psychiatry, 1982 - 1985- University of Vermont Medical CenterResidency, Family Medicine, 1979 - 1982
University of Illinois College of MedicineClass of 1979
Certifications & Licensure
AZ State Medical License 2001 - 2025
NC State Medical License 1997 - 2003
VT State Medical License 1982 - 1998
American Board of Psychiatry and Neurology Psychiatry
American Board of Preventive Medicine Addiction Medicine
Awards, Honors, & Recognition
- Super Doctor SuperDoctors.com
Clinical Trials
- Aripiprazole, Abilify Maintena Collaborative Clinical Protocol Start of enrollment: 2015 Jun 01
Publications & Presentations
PubMed
- 1 citationsSafety of carbamazepine extended-release capsules used in combination with other psychotropic medications for the treatment of bipolar I disorder.Richard H. Weisler, Amir H Kalali, Andrew J. Cutler, Thomas D Gazda, Lawrence Ginsberg
Psychiatry. 2008-05-01 - Efficacy and Safety of Once- versus Twice-Daily Carbamazepine Extended-Release Capsules for the Treatment of Manic Symptoms in Patients with Bipolar I Disorder.Richard H. Weisler, Amir H Kalali, Andrew J. Cutler, Thomas D Gazda, Lawrence Ginsberg
Psychiatry. 2008-03-01 - 2 citationsSwitching from other agents to extended-release carbamazepine in acute mania.Rif S. El-Mallakh, Terence A. Ketter, Richard H. Weisler, Robert M. A. Hirschfeld, Andrew J. Cutler
Psychopharmacology Bulletin. 2008-01-01
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
